Kit For the Preparation of Technetium Tc99m Mertiatide (Page 4 of 4)

Calculations

1. Percent technetium Tc 99m mertiatide =

Activity of 2nd (ethanol/saline) fraction

× 100%

Total activity of all three fractions

2. Percent hydrophilic impurities =

Activity of 1st (0.001N HCl acid) fraction

× 100%

Total activity of all three fractions

3. Percent non-elutable impurities =

Activity remaining on Sep-Pak cartridge

× 100%

Total activity of all three fractions

This reagent kit for the preparation of a radiopharmaceutical is approved for use by persons licensed pursuant to Section 120.547, Code of Massachusetts Regulation 105, or under equivalent license of the U.S. Nuclear Regulatory Commission or an Agreement State.

Sep-Pak is a trademark of Waters Technologies Corporation.

Manufactured by:

Sun Pharmaceutical Industries, Inc.

Billerica, MA 01821 USA

PL-000066

Mar 2020

PRINCIPAL DISPLAY PANEL — Kit Carton

Kit for the Preparation of

Technetium Tc99m Mertiatide

1 mg Betiatide per Vial

For Intravenous Use after Reconstitution

Rx Only

Manufactured by:

Sun Pharmaceutical Industries, Inc.

Billerica, MA 01821

For Customer Service call: 1-800-221-7554

Mertiatide Carton Label
(click image for full-size original)
KIT FOR THE PREPARATION OF TECHNETIUM TC99M MERTIATIDE betiatide injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:45567-0655
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Betiatide (Betiatide) Betiatide 1 mg
Inactive Ingredients
Ingredient Name Strength
Stannous Chloride 0.05 mg
Stannous Chloride Anhydrous 0.2 mg
Sodium Tartrate 40 mg
Lactose Monohydrate 20 mg
Sodium Hydroxide
Hydrochloric Acid
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:45567-0655-1 5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA208994 09/02/2019
Labeler — Sun Pharmaceutical Industries, Inc. (139261648)
Establishment
Name Address ID/FEI Operations
Sun Pharmaceutical Industries, Inc. 139261648 MANUFACTURE (45567-0655)

Revised: 12/2021 Sun Pharmaceutical Industries, Inc.

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.